Kimia Biosciences (BOM:530313) Revenue : ₹ Mil (TTM As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Revenue?

Kimia Biosciences's revenue for the six months ended in . 20 was ₹0.00 Mil. Kimia Biosciences does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in . 20. Kimia Biosciences's Revenue per Share for the six months ended in . 20 was ₹0.00. Kimia Biosciences does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Kimia Biosciences Revenue Historical Data

The historical data trend for Kimia Biosciences's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Revenue Chart

Kimia Biosciences Annual Data

Trend

Revenue

Kimia Biosciences Semi-Annual Data

Revenue

Competitive Comparison of Kimia Biosciences's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kimia Biosciences's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Revenue distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Revenue falls into.

Kimia Biosciences Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Kimia Biosciences (BOM:530313) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Kimia Biosciences Revenue Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Kimia Biosciences (BOM:530313) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Revenue

Traded in Other Exchanges

N/A

Address

Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034

Website

https://www.kimiabiosciences.com

Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines